Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1997 Dec;52(Suppl 5):S1–S28.

BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease

PMCID: PMC1765890  PMID: 9474238

Full Text

The Full Text of this article is available as a PDF (251.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert R. K., Martin T. R., Lewis S. W. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med. 1980 Jun;92(6):753–758. doi: 10.7326/0003-4819-92-6-753. [DOI] [PubMed] [Google Scholar]
  2. Anthonisen N. R., Manfreda J., Warren C. P., Hershfield E. S., Harding G. K., Nelson N. A. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987 Feb;106(2):196–204. doi: 10.7326/0003-4819-106-2-196. [DOI] [PubMed] [Google Scholar]
  3. Anthonisen N. R., Wright E. C. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986 May;133(5):814–819. [PubMed] [Google Scholar]
  4. Anthonisen N. R., Wright E. C. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986 May;133(5):814–819. [PubMed] [Google Scholar]
  5. Anthonisen N. R., Wright E. C., Hodgkin J. E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986 Jan;133(1):14–20. doi: 10.1164/arrd.1986.133.1.14. [DOI] [PubMed] [Google Scholar]
  6. Barker D. J., Godfrey K. M., Fall C., Osmond C., Winter P. D., Shaheen S. O. Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. BMJ. 1991 Sep 21;303(6804):671–675. doi: 10.1136/bmj.303.6804.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bazuaye E. A., Stone T. N., Corris P. A., Gibson G. J. Variability of inspired oxygen concentration with nasal cannulas. Thorax. 1992 Aug;47(8):609–611. doi: 10.1136/thx.47.8.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Blasi F., Legnani D., Lombardo V. M., Negretto G. G., Magliano E., Pozzoli R., Chiodo F., Fasoli A., Allegra L. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J. 1993 Jan;6(1):19–22. [PubMed] [Google Scholar]
  9. Bloom B. S., Daniel J. M., Wiseman M., Knorr R. S., Cebul R., Kissick W. L. Transtracheal oxygen delivery and patients with chronic obstructive pulmonary disease. Respir Med. 1989 Jul;83(4):281–288. doi: 10.1016/s0954-6111(89)80197-0. [DOI] [PubMed] [Google Scholar]
  10. Bott J., Carroll M. P., Conway J. H., Keilty S. E., Ward E. M., Brown A. M., Paul E. A., Elliott M. W., Godfrey R. C., Wedzicha J. A. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet. 1993 Jun 19;341(8860):1555–1557. doi: 10.1016/0140-6736(93)90696-e. [DOI] [PubMed] [Google Scholar]
  11. Braun S. R., McKenzie W. N., Copeland C., Knight L., Ellersieck M. A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease. Arch Intern Med. 1989 Mar;149(3):544–547. [PubMed] [Google Scholar]
  12. Brochard L., Mancebo J., Wysocki M., Lofaso F., Conti G., Rauss A., Simonneau G., Benito S., Gasparetto A., Lemaire F. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995 Sep 28;333(13):817–822. doi: 10.1056/NEJM199509283331301. [DOI] [PubMed] [Google Scholar]
  13. Burrows B., Knudson R. J., Cline M. G., Lebowitz M. D. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis. 1977 Feb;115(2):195–205. doi: 10.1164/arrd.1977.115.2.195. [DOI] [PubMed] [Google Scholar]
  14. Calverley P. M., Howatson R., Flenley D. C., Lamb D. Clinicopathological correlations in cor pulmonale. Thorax. 1992 Jul;47(7):494–498. doi: 10.1136/thx.47.7.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cockcroft A., Bagnall P., Heslop A., Andersson N., Heaton R., Batstone J., Allen J., Spencer P., Guz A. Controlled trial of respiratory health worker visiting patients with chronic respiratory disability. Br Med J (Clin Res Ed) 1987 Jan 24;294(6566):225–228. doi: 10.1136/bmj.294.6566.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Connolly M. J., Crowley J. J., Charan N. B., Nielson C. P., Vestal R. E. Reduced subjective awareness of bronchoconstriction provoked by methacholine in elderly asthmatic and normal subjects as measured on a simple awareness scale. Thorax. 1992 Jun;47(6):410–413. doi: 10.1136/thx.47.6.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cooper C. B., Davidson A. C., Cameron I. R. Aminophylline, respiratory muscle strength and exercise tolerance in chronic obstructive airway disease. Bull Eur Physiopathol Respir. 1987 Jan-Feb;23(1):15–22. [PubMed] [Google Scholar]
  18. Doll R., Peto R., Wheatley K., Gray R., Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994 Oct 8;309(6959):901–911. doi: 10.1136/bmj.309.6959.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dunn W. F., Nelson S. B., Hubmayr R. D. Oxygen-induced hypercarbia in obstructive pulmonary disease. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):526–530. doi: 10.1164/ajrccm/144.3_Pt_1.526. [DOI] [PubMed] [Google Scholar]
  20. Evans W. V. Plasma theophylline concentrations, six minute walking distances, and breathlessness in patients with chronic airflow obstruction. Br Med J (Clin Res Ed) 1984 Dec 15;289(6459):1649–1651. doi: 10.1136/bmj.289.6459.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fernandez A., Muñoz J., de la Calle B., Alia I., Ezpeleta A., de la Cal M. A., Reyes A. Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med. 1994;20(3):199–202. doi: 10.1007/BF01704700. [DOI] [PubMed] [Google Scholar]
  22. Fitting J. W. Nutritional support in chronic obstructive lung disease. Thorax. 1992 Mar;47(3):141–143. doi: 10.1136/thx.47.3.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fletcher C., Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977 Jun 25;1(6077):1645–1648. doi: 10.1136/bmj.1.6077.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. France A. J., Prescott R. J., Biernacki W., Muir A. L., MacNee W. Does right ventricular function predict survival in patients with chronic obstructive lung disease? Thorax. 1988 Aug;43(8):621–626. doi: 10.1136/thx.43.8.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Goldacre M. J., Ferguson J. A. In-patient workload in medical specialties: 1. Demographic profiles and time trends from linked statistics. QJM. 1995 Sep;88(9):649–659. [PubMed] [Google Scholar]
  26. Goldstein R. S., Gort E. H., Stubbing D., Avendano M. A., Guyatt G. H. Randomised controlled trial of respiratory rehabilitation. Lancet. 1994 Nov 19;344(8934):1394–1397. doi: 10.1016/s0140-6736(94)90568-1. [DOI] [PubMed] [Google Scholar]
  27. Gross N. J., Co E., Skorodin M. S. Cholinergic bronchomotor tone in COPD. Estimates of its amount in comparison with that in normal subjects. Chest. 1989 Nov;96(5):984–987. doi: 10.1378/chest.96.5.984. [DOI] [PubMed] [Google Scholar]
  28. Gross N. J., Petty T. L., Friedman M., Skorodin M. S., Silvers G. W., Donohue J. F. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Am Rev Respir Dis. 1989 May;139(5):1188–1191. doi: 10.1164/ajrccm/139.5.1188. [DOI] [PubMed] [Google Scholar]
  29. Grove A., Lipworth B. J., Reid P., Smith R. P., Ramage L., Ingram C. G., Jenkins R. J., Winter J. H., Dhillon D. P. Effects of regular salmeterol on lung function and exercise capacity in patients with chronic obstructive airways disease. Thorax. 1996 Jul;51(7):689–693. doi: 10.1136/thx.51.7.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Guyatt G. H., Townsend M., Nogradi S., Pugsley S. O., Keller J. L., Newhouse M. T. Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. Arch Intern Med. 1988 Sep;148(9):1949–1952. doi: 10.1001/archinte.148.9.1949. [DOI] [PubMed] [Google Scholar]
  31. Guyatt G. Measuring health status in chronic airflow limitation. Eur Respir J. 1988 Jun;1(6):560–564. [PubMed] [Google Scholar]
  32. Hay J. G., Stone P., Carter J., Church S., Eyre-Brook A., Pearson M. G., Woodcock A. A., Calverley P. M. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J. 1992 Jun;5(6):659–664. [PubMed] [Google Scholar]
  33. Hunter A. M., Carey M. A., Larsh H. W. The nutritional status of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1981 Oct;124(4):376–381. doi: 10.1164/arrd.1981.124.4.376. [DOI] [PubMed] [Google Scholar]
  34. Jamrozik K., Vessey M., Fowler G., Wald N., Parker G., Van Vunakis H. Controlled trial of three different antismoking interventions in general practice. Br Med J (Clin Res Ed) 1984 May 19;288(6429):1499–1503. doi: 10.1136/bmj.288.6429.1499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Janus E. D., Phillips N. T., Carrell R. W. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet. 1985 Jan 19;1(8421):152–154. doi: 10.1016/s0140-6736(85)91916-6. [DOI] [PubMed] [Google Scholar]
  36. Jenkins S. C., Heaton R. W., Fulton T. J., Moxham J. Comparison of domiciliary nebulized salbutamol and salbutamol from a metered-dose inhaler in stable chronic airflow limitation. Chest. 1987 Jun;91(6):804–807. doi: 10.1378/chest.91.6.804. [DOI] [PubMed] [Google Scholar]
  37. Jones P. W., Quirk F. H., Baveystock C. M., Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321–1327. doi: 10.1164/ajrccm/145.6.1321. [DOI] [PubMed] [Google Scholar]
  38. Juniper E. F., Guyatt G. H., Ferrie P. J., Griffith L. E. Measuring quality of life in asthma. Am Rev Respir Dis. 1993 Apr;147(4):832–838. doi: 10.1164/ajrccm/147.4.832. [DOI] [PubMed] [Google Scholar]
  39. Kelly C. A., Gibson G. J. Relation between FEV1 and peak expiratory flow in patients with chronic airflow obstruction. Thorax. 1988 Apr;43(4):335–336. doi: 10.1136/thx.43.4.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kesten S., Chapman K. R. Physician perceptions and management of COPD. Chest. 1993 Jul;104(1):254–258. doi: 10.1378/chest.104.1.254. [DOI] [PubMed] [Google Scholar]
  41. Kim W. D., Eidelman D. H., Izquierdo J. L., Ghezzo H., Saetta M. P., Cosio M. G. Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities. Am Rev Respir Dis. 1991 Dec;144(6):1385–1390. doi: 10.1164/ajrccm/144.6.1385. [DOI] [PubMed] [Google Scholar]
  42. Korn R. J., Dockery D. W., Speizer F. E., Ware J. H., Ferris B. G., Jr Occupational exposures and chronic respiratory symptoms. A population-based study. Am Rev Respir Dis. 1987 Aug;136(2):298–304. doi: 10.1164/ajrccm/136.2.298. [DOI] [PubMed] [Google Scholar]
  43. Lam W., Sze P. C., Sacks H. S., Chalmers T. C. Meta-analysis of randomised controlled trials of nicotine chewing-gum. Lancet. 1987 Jul 4;2(8549):27–30. doi: 10.1016/s0140-6736(87)93061-3. [DOI] [PubMed] [Google Scholar]
  44. Leitch A. G., Hopkin J. M., Ellis D. A., Merchant S., McHardy G. J. The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax. 1978 Dec;33(6):711–713. doi: 10.1136/thx.33.6.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. Am J Respir Crit Care Med. 1994 Sep;150(3):833–852. doi: 10.1164/ajrccm.150.3.8087359. [DOI] [PubMed] [Google Scholar]
  46. Meecham Jones D. J., Paul E. A., Grahame-Clarke C., Wedzicha J. A. Nasal ventilation in acute exacerbations of chronic obstructive pulmonary disease: effect of ventilator mode on arterial blood gas tensions. Thorax. 1994 Dec;49(12):1222–1224. doi: 10.1136/thx.49.12.1222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mitchell-Heggs P., Murphy K., Minty K., Guz A., Patterson S. C., Minty P. S., Rosser R. M. Diazepam in the treatment of dyspnoea in the 'Pink Puffer' syndrome. Q J Med. 1980 Winter;49(193):9–20. [PubMed] [Google Scholar]
  48. Moayyedi P., Congleton J., Page R. L., Pearson S. B., Muers M. F. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. Thorax. 1995 Aug;50(8):834–837. doi: 10.1136/thx.50.8.834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Morgan A. D., Peck D. F., Buchanan D., McHardy G. J. Psychological factors contributing to disproportionate disability in chronic bronchitis. J Psychosom Res. 1983;27(4):259–263. doi: 10.1016/0022-3999(83)90047-8. [DOI] [PubMed] [Google Scholar]
  50. Morgan M. D., Denison D. M., Strickland B. Value of computed tomography for selecting patients with bullous lung disease for surgery. Thorax. 1986 Nov;41(11):855–862. doi: 10.1136/thx.41.11.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Morrison D., Skwarski K., MacNee W. Review of the prescription of domiciliary long term oxygen therapy in Scotland. Thorax. 1995 Oct;50(10):1103–1105. doi: 10.1136/thx.50.10.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Morrison J. F., Jones P. C., Muers M. F. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation. Eur Respir J. 1992 Apr;5(4):424–429. [PubMed] [Google Scholar]
  53. Murciano D., Aubier M., Lecocguic Y., Pariente R. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med. 1984 Aug 9;311(6):349–353. doi: 10.1056/NEJM198408093110601. [DOI] [PubMed] [Google Scholar]
  54. Nagai A., Thurlbeck W. M., Konno K. Responsiveness and variability of airflow obstruction in chronic obstructive pulmonary disease. Clinicopathologic correlative studies. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):635–639. doi: 10.1164/ajrccm/151.3_Pt_1.635. [DOI] [PubMed] [Google Scholar]
  55. Newhouse M., Dolovich M. Aerosol therapy: nebulizer vs metered dose inhaler. Chest. 1987 Jun;91(6):799–800. doi: 10.1378/chest.91.6.799. [DOI] [PubMed] [Google Scholar]
  56. Nisar M., Earis J. E., Pearson M. G., Calverley P. M. Acute bronchodilator trials in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Sep;146(3):555–559. doi: 10.1164/ajrccm/146.3.555. [DOI] [PubMed] [Google Scholar]
  57. Nisar M., Earis J. E., Pearson M. G., Calverley P. M. Acute bronchodilator trials in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Sep;146(3):555–559. doi: 10.1164/ajrccm/146.3.555. [DOI] [PubMed] [Google Scholar]
  58. Nisar M., Walshaw M., Earis J. E., Pearson M. G., Calverley P. M. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease. Thorax. 1990 Mar;45(3):190–194. doi: 10.1136/thx.45.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. O'Connor G. T., Sparrow D., Weiss S. T. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989 Jul;140(1):225–252. doi: 10.1164/ajrccm/140.1.225. [DOI] [PubMed] [Google Scholar]
  60. O'Driscoll B. R., Kay E. A., Taylor R. J., Weatherby H., Chetty M. C., Bernstein A. A long-term prospective assessment of home nebulizer treatment. Respir Med. 1992 Jul;86(4):317–325. doi: 10.1016/s0954-6111(06)80031-4. [DOI] [PubMed] [Google Scholar]
  61. O'Driscoll B. R., Taylor R. J., Horsley M. G., Chambers D. K., Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet. 1989 Jun 24;1(8652):1418–1420. doi: 10.1016/s0140-6736(89)90126-8. [DOI] [PubMed] [Google Scholar]
  62. Ollerenshaw S. L., Woolcock A. J. Characteristics of the inflammation in biopsies from large airways of subjects with asthma and subjects with chronic airflow limitation. Am Rev Respir Dis. 1992 Apr;145(4 Pt 1):922–927. doi: 10.1164/ajrccm/145.4_Pt_1.922. [DOI] [PubMed] [Google Scholar]
  63. Oxman A. D., Muir D. C., Shannon H. S., Stock S. R., Hnizdo E., Lange H. J. Occupational dust exposure and chronic obstructive pulmonary disease. A systematic overview of the evidence. Am Rev Respir Dis. 1993 Jul;148(1):38–48. doi: 10.1164/ajrccm/148.1.38. [DOI] [PubMed] [Google Scholar]
  65. Pearson M. G., Ogilvie C. Surgical treatment of emphysematous bullae: late outcome. Thorax. 1983 Feb;38(2):134–137. doi: 10.1136/thx.38.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Postma D. S., Peters I., Steenhuis E. J., Sluiter H. J. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? Eur Respir J. 1988 Jan;1(1):22–26. [PubMed] [Google Scholar]
  67. Postma D. S., de Vries K., Koëter G. H., Sluiter H. J. Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction. Am Rev Respir Dis. 1986 Aug;134(2):276–280. doi: 10.1164/arrd.1986.134.2.276. [DOI] [PubMed] [Google Scholar]
  68. Restrick L. J., Paul E. A., Braid G. M., Cullinan P., Moore-Gillon J., Wedzicha J. A. Assessment and follow up of patients prescribed long term oxygen treatment. Thorax. 1993 Jul;48(7):708–713. doi: 10.1136/thx.48.7.708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group. BMJ. 1992 Sep 5;305(6853):567–574. doi: 10.1136/bmj.305.6853.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Roberts C. M., Bugler J. R., Melchor R., Hetzel M. R., Spiro S. G. Value of pulse oximetry in screening for long-term oxygen therapy requirement. Eur Respir J. 1993 Apr;6(4):559–562. [PubMed] [Google Scholar]
  71. Russell M. A., Stapleton J. A., Feyerabend C., Wiseman S. M., Gustavsson G., Sawe U., Connor P. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches. BMJ. 1993 May 15;306(6888):1308–1312. doi: 10.1136/bmj.306.6888.1308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Saetta M., Di Stefano A., Maestrelli P., Ferraresso A., Drigo R., Potena A., Ciaccia A., Fabbri L. M. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis. 1993 Feb;147(2):301–306. doi: 10.1164/ajrccm/147.2.301. [DOI] [PubMed] [Google Scholar]
  73. Scott J. P., Higenbottam T. W., Sharples L., Clelland C. A., Smyth R. L., Stewart S., Wallwork J. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation. 1991 Apr;51(4):813–817. doi: 10.1097/00007890-199104000-00015. [DOI] [PubMed] [Google Scholar]
  74. Shapiro E. D., Berg A. T., Austrian R., Schroeder D., Parcells V., Margolis A., Adair R. K., Clemens J. D. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991 Nov 21;325(21):1453–1460. doi: 10.1056/NEJM199111213252101. [DOI] [PubMed] [Google Scholar]
  75. Siafakas N. M., Vermeire P., Pride N. B., Paoletti P., Gibson J., Howard P., Yernault J. C., Decramer M., Higenbottam T., Postma D. S. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995 Aug;8(8):1398–1420. doi: 10.1183/09031936.95.08081398. [DOI] [PubMed] [Google Scholar]
  76. Smith K., Cook D., Guyatt G. H., Madhavan J., Oxman A. D. Respiratory muscle training in chronic airflow limitation: a meta-analysis. Am Rev Respir Dis. 1992 Mar;145(3):533–539. doi: 10.1164/ajrccm/145.3.533. [DOI] [PubMed] [Google Scholar]
  77. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 2):S77–121. [PubMed] [Google Scholar]
  78. Storms W. W., Bodman S. F., Nathan R. A., Busse W. W., Bush R. K., Falliers C. J., O'Hollaren J. D., Weg J. G. Use of ipratropium bromide in asthma. Results of a multi-clinic study. Am J Med. 1986 Nov 14;81(5A):61–66. doi: 10.1016/0002-9343(86)90464-x. [DOI] [PubMed] [Google Scholar]
  79. Sutton P. P. Chest physiotherapy: time for reappraisal. Br J Dis Chest. 1988 Apr;82(2):127–137. doi: 10.1016/0007-0971(88)90032-0. [DOI] [PubMed] [Google Scholar]
  80. Thurlbeck W. M., Simon G. Radiographic appearance of the chest in emphysema. AJR Am J Roentgenol. 1978 Mar;130(3):429–440. doi: 10.2214/ajr.130.3.429. [DOI] [PubMed] [Google Scholar]
  81. Traver G. A., Cline M. G., Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis. 1979 Jun;119(6):895–902. doi: 10.1164/arrd.1979.119.6.895. [DOI] [PubMed] [Google Scholar]
  82. Traver G. A., Cline M. G., Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis. 1979 Jun;119(6):895–902. doi: 10.1164/arrd.1979.119.6.895. [DOI] [PubMed] [Google Scholar]
  83. Tsiu S. J., Self T. H., Burns R. Theophylline toxicity: update. Ann Allergy. 1990 Feb;64(2 Pt 2):241–257. [PubMed] [Google Scholar]
  84. Ulrik C. S. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. Thorax. 1995 Jul;50(7):750–754. doi: 10.1136/thx.50.7.750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Vitacca M., Rubini F., Foglio K., Scalvini S., Nava S., Ambrosino N. Non-invasive modalities of positive pressure ventilation improve the outcome of acute exacerbations in COLD patients. Intensive Care Med. 1993;19(8):450–455. doi: 10.1007/BF01711086. [DOI] [PubMed] [Google Scholar]
  86. Walshaw M. J., Lim R., Evans C. C., Hind C. R. Prescription of oxygen concentrators for long term oxygen treatment: reassessment in one district. BMJ. 1988 Oct 22;297(6655):1030–1032. doi: 10.1136/bmj.297.6655.1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Weir D. C., Gove R. I., Robertson A. S., Burge P. S. Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax. 1990 Feb;45(2):112–117. doi: 10.1136/thx.45.2.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Weitzenblum E., Hirth C., Ducolone A., Mirhom R., Rasaholinjanahary J., Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981 Oct;36(10):752–758. doi: 10.1136/thx.36.10.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Wijkstra P. J., Van Altena R., Kraan J., Otten V., Postma D. S., Koëter G. H. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J. 1994 Feb;7(2):269–273. doi: 10.1183/09031936.94.07020269. [DOI] [PubMed] [Google Scholar]
  90. Wolkove N., Dajczman E., Colacone A., Kreisman H. The relationship between pulmonary function and dyspnea in obstructive lung disease. Chest. 1989 Dec;96(6):1247–1251. doi: 10.1378/chest.96.6.1247. [DOI] [PubMed] [Google Scholar]
  91. Woodcock A. A., Gross E. R., Gellert A., Shah S., Johnson M., Geddes D. M. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981 Dec 31;305(27):1611–1616. doi: 10.1056/NEJM198112313052703. [DOI] [PubMed] [Google Scholar]
  92. van Schayck C. P., Dompeling E., van Herwaarden C. L., Folgering H., Verbeek A. L., van der Hoogen H. J., van Weel C. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ. 1991 Dec 7;303(6815):1426–1431. doi: 10.1136/bmj.303.6815.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. van Schayck C. P., Folgering H., Harbers H., Maas K. L., van Weel C. Effects of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. Thorax. 1991 May;46(5):355–359. doi: 10.1136/thx.46.5.355. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES